Alx Oncology Holdings's three largest insider shareholders as of March 23, 2026 are Corey S Goodman (Director, 8.45Mn shares), Jaume Pons (President Cso, 579.39K shares), Sophia Randolph (Chief Medical Officer, 325.71K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Corey S Goodman | 0 | 8,453,038 | 04 Feb, 2026 | |
| Jaume Pons | President Cso | 579,388 | 0 | 21 Feb, 2025 |
| Sophia Randolph | Chief Medical Officer | 325,711 | 0 | 16 Aug, 2024 |
| Jason Lettmann | Chief Executive Officer | 293,609 | 0 | 23 Mar, 2026 |
| Jason Lettmann | 0 | 285,956 | 15 Dec, 2021 | |
| Associates, Llc Lsv | 0 | 285,956 | 15 Dec, 2021 | |
| Peter S Garcia | Chief Financial Officer | 121,516 | 0 | 16 Aug, 2024 |
| Shelly Pinto | Svp, Finance And Cao | 86,805 | 0 | 23 Mar, 2026 |
| Harish Shantharam | Chief Financial Officer | 75,000 | 0 | 20 Aug, 2025 |
| Rekha Hemrajani | 33,000 | 0 | 04 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Mar, 2026 | Jason Lettmann | Common Stock | D | 12,311 | $2.17 | 293,609 | D | S |
| 19 Mar, 2026 | Shelly Pinto | Common Stock | D | 903 | $2.17 | 86,805 | D | S |
| 03 Mar, 2026 | Barbara Klencke | Stock option (right to buy) | A | 700,000 | $0.00 | 700,000 | D | A |
| 18 Feb, 2026 | Shelly Pinto | Common Stock | D | 565 | $2.27 | 87,708 | D | S |
| 17 Feb, 2026 | Jason Lettmann | Common Stock | D | 2,201 | $2.27 | 305,920 | D | F |
| 02 Feb, 2026 | Corey S Goodman | Common Stock | A | 3,184,713 | $1.57 | 8,453,038 | I | P |
| 26 Jan, 2026 | Shelly Pinto | Stock option (right to buy) | A | 192,000 | $0.00 | 192,000 | D | A |
| 26 Jan, 2026 | Jason Lettmann | Stock option (right to buy) | A | 912,000 | $0.00 | 912,000 | D | A |
| 26 Jan, 2026 | Harish Shantharam | Stock option (right to buy) | A | 303,000 | $0.00 | 303,000 | D | A |
| 20 Jan, 2026 | Rekha Hemrajani | Stock option (right to buy) | A | 40,400 | $0.00 | 40,400 | D | A |
| 20 Jan, 2026 | Alan B. Sandler | Stock option (right to buy) | A | 10,100 | $0.00 | 10,100 | D | A |
| 20 Jan, 2026 | Chris H Takimoto | Stock option (right to buy) | A | 40,400 | $0.00 | 40,400 | D | A |
| 20 Jan, 2026 | Corey S Goodman | Stock Option (right to buy) | A | 40,400 | $0.00 | 40,400 | D | A |
| 20 Jan, 2026 | Daniel J. Curran | Stock Option (right to buy) | A | 16,833 | $0.00 | 16,833 | D | A |
| 20 Jan, 2026 | J. Scott Garland | Stock option (right to buy) | A | 40,400 | $0.00 | 40,400 | D | A |
| 06 Jan, 2026 | Shelly Pinto | Common Stock | D | 3,925 | $1.11 | 88,273 | D | S |
| 14 Oct, 2025 | Shelly Pinto | Employee Stock Option (right to buy) | A | 140,000 | $0.00 | 140,000 | D | A |
| 14 Oct, 2025 | Jason Lettmann | Employee Stock Option (right to buy) | A | 597,500 | $0.00 | 597,500 | D | A |
| 14 Oct, 2025 | Harish Shantharam | Employee Stock Option (right to buy) | A | 198,750 | $0.00 | 198,750 | D | A |
| 17 Sep, 2025 | Barbara Klencke | Stock option (right to buy) | A | 300,000 | $0.00 | 300,000 | D | A |